Inventor · disambiguated record
Heping Wu
Also filed as: WU HEPING
13 granted patents·7 pending applications·26 citations·filing 2008–2022
87Inventor score
Files withMERCK SHARP & DOHME11TING PAULINE C3ETERNITY BIOSCIENCE INC2BOYCE CHRISTOPHER W1DEVITA ROBERT J1
Top patents by PatentIndex Score
20 records- 0186US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0283US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 0383US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 0481US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 0579US9783530B2Factor Xla inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 10, 2017·2 cites·14 claims
- 0677US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 0775US10822338B2Substituted aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 3, 2020·2 cites·17 claims
- 0874US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 0973US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1063US8232274B2Pyridazinone derivatives useful as glucan synthase inhibitorsTING PAULINE C·Filed 2008·Granted Jul 31, 2012·1 cites·20 claims
- 1154US2022135539A1Biaryl amide compounds, preparation methods and medical applications thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1254US2024076297A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1353US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 1452US2011224193A1Inhibitors of diacylglycerol acyltransferaseMERCK SHARP & DOHME·Filed 2009·Application pending·0 cites
- 1550US2022002267A1Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1647US11332492B2CD73 inhibitors and therapeutic uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted May 17, 2022·0 cites·23 claims
- 1747US8716312B2Inhibitors of diacylglycerol acyltransferaseTING PAULINE C·Filed 2009·Granted May 6, 2014·0 cites·6 claims
- 1847US2011224136A1Inhibitors of diacylglycerol acyltransferaseTING PAULINE C·Filed 2009·Application pending·0 cites
- 1943US11046714B22,2-difluorodioxolo A2A receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jun 29, 2021·0 cites·14 claims
- 2035US2014088124A1Imidazole derivativesDEVITA ROBERT J·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heping Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →